Fig. 3From: Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related diseaseChanges in serum total IgE levels (black circle) and blood eosinophil counts (grey diamond) during the treatment course. RES: Reslizumab; OCS: oral corticosteroidBack to article page